Delivery Order SPE2DB22D3016-SPE2DB24FAPL3
Award Date 3/7/24
Potential Completion Date 3/8/24
Potential Value $6.1K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $6,544.95 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide COSENTYX SNRDY 300MG DOSE-2PENML pharmaceutical products. This delivery order is issued under Amerisourcebergen's existing indefinite delivery contract (IDC) with DLA, which has a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $15,047.26 firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide COSENTYX SNRDY 300MG DOSE-2PENML pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00, which serves as the primary vehicle for Amerisourcebergen to deliver pharmaceuticals and medical supplies to DLA Troop Support Medical...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide COSENTYX SNRDY 300MG DOSE-2PENML pharmaceuticals. The contract has a potential value of $4,734.61 and a completion date of March 8, 2024. This delivery order contract is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA with a potential value of $999,999,999.00 and a...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract worth $3,451.95 by the Defense Logistics Agency (DLA) to provide COSENTYX SNRDY 300MG DOSE-2PENML pharmaceuticals. This delivery order is issued under an indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract valued at $3,139.00 by the Defense Logistics Agency (DLA). The contract is for the delivery of COSENTYX SNRDY 300MG DOSE-2PENML, a pharmaceutical product, with a completion date of January 26, 2024. This contract is not associated with a set-aside program. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) awarded by...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $7,120.33 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to provide the pharmaceutical product COSENTYX SNRDY 300MG DOSE-2PENML. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide COSENTYX SNRDY 300MG DOSE-2PENML pharmaceuticals. The $12,203.58 contract has a performance period through March 5, 2024. The award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a period of performance through December 31, 2025, which serves as...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a $9,344.10 firm fixed price delivery order from the Defense Logistics Agency (DLA) to provide COSENTYX SNRDY 300MG DOSE-2PENML, a specialty pharmaceutical product. This award is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 held by Amerisourcebergen Drug Corp to deliver pharmaceutical products and medical supplies in support of Department of Defense military...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $9,131.70 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide "COSENTYX SNRDY 300MG DOSE-2PENML" pharmaceutical supplies. This contract has a completion date of January 31, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp is also the prime contractor on a $999,999,999.00 indefinite delivery contract (IDC) with DLA to deliver...
- Amerisourcebergen Drug Corp, through its Corporate Office division in Conshohocken, Pennsylvania, has been awarded a $1,521.95 firm fixed price delivery order contract by the Defense Logistics Agency to provide COSENTYX SNRDY 300MG DOSE-2PENML pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a period of performance through December 31, 2025. The IDC...